Literature DB >> 7997032

Clarithromycin for atypical mycobacterial lymphadenitis in non-immunocompromised children.

M H Tessier, J C Amoric, F Méchinaud, D Dubesset, P Litoux, J F Stalder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7997032     DOI： 10.1016/s0140-6736(94)92920-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Lymphadenopathy.

Authors:  J E Clark; A J Cant
Journal:  Arch Dis Child       Date:  1996-04       Impact factor: 3.791

Review 2.  [Management of atypical cervical mycobacteriosis in childhood].

Authors:  T van Bremen; E Biesinger; F Göke; S Keiner; F Bootz; A Schröck
Journal:  HNO       Date:  2014-04       Impact factor: 1.284

3.  Atypical mycobacterial cervical lymphadenitis with extensive local spread: a surgical disease.

Authors:  M Hogan; D Price; K Burrage; C Pushpanathan
Journal:  Pediatr Surg Int       Date:  2005-10-20       Impact factor: 1.827

4.  Current trends in nontuberculous mycobacteria infections in Canadian children: A pediatric investigators collaborative network on infections in Canada (PICNIC) study.

Authors:  Anne Pham-Huy; Joan L Robinson; Bruce Tapiéro; Chantal Bernard; Sam Daniel; Simon Dobson; Pierre Déry; Nicole Le Saux; Joanne Embree; Louis Valiquette; Caroline Quach
Journal:  Paediatr Child Health       Date:  2010-05       Impact factor: 2.253

5.  In vitro susceptibility of Mycobacterium ulcerans to clarithromycin.

Authors:  F Portaels; H Traore; K De Ridder; W M Meyers
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

6.  First Canadian Reports of Cervical Adenitis Due to Mycobacterium Malmoense and a 10-year Review of Nontuberculous Mycobacterial Adenitis.

Authors:  Chris McCrossin; Tim Mailman
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-03       Impact factor: 2.471

7.  Three cases of atypical mycobacterial cervical adenitis.

Authors:  Mary-Louise Montague; S S Musheer Hussain; Robin L Blair
Journal:  J R Soc Med       Date:  2003-03       Impact factor: 18.000
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.